Explore Our Network

Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.

Showing 5 Patents
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors

21-01-2025 • US-12202810-B2

SHAPIRO, PAUL S. • MACKERELL, JR., ALEXANDER D. • HASDAY, JEFFREY D. • FLETCHER, STEVEN

University of Maryland Baltimore

Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof

27-02-2024 • US-11911393-B2

SHAPIRO, PAUL S. • MACKERELL, JR., ALEXANDER D. • HASDAY, JEFFREY D.

US Department of Veterans Affairs

Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof

27-02-2024 • US-11911392-B2

SHAPIRO, PAUL S. • MACKERELL, JR., ALEXANDER D. • HASDAY, JEFFREY D.

US Department of Veterans Affairs

RUNX2 transcription factor inhibitors and uses thereof

25-04-2023 • US-11634381-B2

PASSANITI, ANTONINO • MACKERELL, JR., ALEXANDER D.

US Department of Veterans Affairs

Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof

14-06-2022 • US-11357781-B2

SHAPIRO, PAUL S. • MACKERELL, JR., ALEXANDER D. • HASDAY, JEFFREY D.

US Department of Veterans Affairs

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.